{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:45:48Z","timestamp":1789577148892,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) exhibits significant clinical heterogeneity, particularly in motor symptom progression. This study aims to identify distinct trajectories of motor progression in PD and explore associated predictive factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained from the Parkinson\u2019s Progression Markers Initiative (PPMI) database on [2025-3-25]. Motor symptom severity was measured using the MDS-UPDRS III scores. Latent class trajectory analysis was used to identify distinct progression patterns. Multinomial logistic regression and machine learning models were used to evaluate predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Three distinct motor progression trajectories were identified: slow progression (38%), moderate progression (55.9%), and rapid progression (6.1%). Compared to the slow progression group, a higher baseline MDS-UPDRS III score was strongly associated with both moderate (OR\u202f=\u202f1.27, 95% CI: 1.23\u20131.31,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and rapid progression (OR\u202f=\u202f1.49, 95% CI: 1.43\u20131.57,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Lower serum albumin levels also significantly increased the likelihood of moderate (OR\u202f=\u202f0.95, 95% CI: 0.91\u20130.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.014) and rapid progression (OR\u202f=\u202f0.89, 95% CI: 0.81\u20130.98,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.016). Additionally, higher baseline BMI (per 5\u202fkg\/m\n                      <jats:sup>2<\/jats:sup>\n                      increase) was associated with greater odds of moderate (OR\u202f=\u202f1.19, 95% CI: 1.01\u20131.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.042). Finally, each 1-unit lower mean striatum specific binding ratio (SBR) reduced the odds of moderate progression by 32% compared with the slow-progression group (OR\u202f=\u202f0.68, 95% CI: 0.46\u20130.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.044). Machine learning analysis confirmed the predictive importance of these factors, with the Random Forest model achieving an AUC of 0.950.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline motor severity, dopaminergic imaging, nutritional status, and body weight are key predictors of motor progression in PD. These findings highlight the potential for early risk stratification and personalized management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2026.1759090","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:40:25Z","timestamp":1771569625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with longitudinal MDS-UPDRS III score trajectories in early-stage Parkinson\u2019s disease"],"prefix":"10.3389","volume":"20","author":[{"given":"Wen","family":"Zhou","sequence":"first","affiliation":[{"name":"West China School of Medicine, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu Second People\u2019s Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Liu","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu Second People\u2019s Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-fang","family":"Zeng","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu Second People\u2019s Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Xia","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu Second People\u2019s Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1021\/jacs.0c01894","article-title":"Molecular mechanism for the suppression of alpha synuclein membrane toxicity by an unconventional extracellular chaperone","volume":"142","author":"Ahmed","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.ejcn.1601581","article-title":"Is under weightness still a major problem in Parkinson\u2019s disease patients?","volume":"57","author":"Barichella","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1021\/acs.jpcb.9b02381","article-title":"Dissecting the interactions between human serum albumin and \u03b1-synuclein: new insights on the factors influencing \u03b1-synuclein aggregation in biological fluids","volume":"123","author":"Bellomo","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1007\/s00415-024-12645-1","article-title":"Disease progression subtypes of Parkinson\u2019s disease based on milestone events","volume":"271","author":"Chen","year":"2024","journal-title":"J. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mds.28412","article-title":"Impact of obstructive sleep apnea on cognitive and motor functions in Parkinson\u2019s disease","volume":"36","author":"Elfil","year":"2021","journal-title":"Mov. Disord."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"107174","DOI":"10.1016\/j.parkreldis.2024.107174","article-title":"Trajectory of change in body mass index in parkinson\u2019s disease","volume":"130","author":"Henderson","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bbamem.2018.01.015","article-title":"Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein","volume":"1860","author":"Kakinen","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jamda.2019.11.019","article-title":"Impact of overweight and obesity on functional and clinical outcomes of early parkinson\u2019s disease","volume":"21","author":"Kim","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archneur.56.3.334","article-title":"Progression of parkinsonian signs in Parkinson disease","volume":"56","author":"Louis","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","article-title":"Parkinson\u2019s disease subtypes: lost in translation?","volume":"84","author":"Marras","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1590\/s0004-282x2012001100004","article-title":"Overweight is more prevalent in patients with parkinson\u2019s disease","volume":"70","author":"Morales-Brice\u00f1o","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/1533317517714887","article-title":"Frontal tasks and behavior in rigid or tremor-dominant parkinson disease","volume":"32","author":"Moretti","year":"2017","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e1301","DOI":"10.1002\/widm.1301","article-title":"Hyperparameters and tuning strategies for random forest","volume":"9","author":"Probst","year":"2019","journal-title":"WIREs Data Min Knowl"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/WNL.0000000000004078","article-title":"Baseline motor findings and parkinson disease prognostic subtypes","volume":"89","author":"Rajput","year":"2017","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/ene.12476","article-title":"Clinical evolution of parkinson\u2019s disease and prognostic factors affecting motor progression: 9-year follow-up study","volume":"22","author":"Reinoso","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.7754\/clin.lab.2012.121115","article-title":"Human serum albumin and its relation with oxidative stress","volume":"59","author":"Sitar","year":"2013","journal-title":"Clin. Lab."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.3390\/ijms25137102","article-title":"GBA1-associated parkinson\u2019s disease is a distinct entity","volume":"25","author":"Skrahin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/mds.28536","article-title":"Changes in body composition before and after parkinson\u2019s disease diagnosis","volume":"36","author":"Song","year":"2021","journal-title":"Mov. Disord."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/02692155241272967","article-title":"Relationships between physical activities performed under free-living conditions and non-motor symptoms in people with parkinson\u2019s: a systematic review and meta-analysis","volume":"38","author":"Still","year":"2024","journal-title":"Clin. Rehabil."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e30324","DOI":"10.1097\/MD.0000000000030324","article-title":"Serum albumin, cognitive function, motor impairment, and survival prognosis in parkinson disease","volume":"101","author":"Sun","year":"2022","journal-title":"Medicine"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of parkinson\u2019s disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov. Disord."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/mds.20837","article-title":"Predictors of weight loss in parkinson\u2019s disease","volume":"21","author":"Uc","year":"2006","journal-title":"Mov. Disord."},{"key":"ref25","first-page":"109","article-title":"Categorical data analysis by a. Agresti","volume":"170","author":"Upton","year":"1995","journal-title":"Public Utilites"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.parkreldis.2011.04.002","article-title":"Estimation of further disease progression of parkinson\u2019s disease by dopamin transporter scan vs clinical rating","volume":"17","author":"Vogt","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10072-016-2738-z","article-title":"Impact of serum uric acid, albumin and their interaction on parkinson\u2019s disease","volume":"38","author":"Wang","year":"2017","journal-title":"Neurol. Sci."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamaneurol.2015.4265","article-title":"Association between change in body mass index, unified parkinson\u2019s disease rating scale scores, and survival among persons with parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in parkinson disease long-term study 1","volume":"73","author":"Wills","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v077.i01","article-title":"Ranger: a fast implementation of random forests for high dimensional data in C++ and R","volume":"77","author":"Wright","year":"2017","journal-title":"J. Stat. Softw."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"107305","DOI":"10.1016\/j.parkreldis.2025.107305","article-title":"The HALP score differs among sporadic and familial Parkinson\u2019s disease","volume":"133","author":"Zhou","year":"","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1635817","DOI":"10.3389\/fpsyt.2025.1635817","article-title":"Association between inflammatory markers (SII and SIRI) and anxiety levels in Parkinson\u2019s disease","volume":"16","author":"Zhou","year":"","journal-title":"Front. Psych."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1759090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:40:27Z","timestamp":1771569627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1759090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":30,"alternative-id":["10.3389\/fnins.2026.1759090"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1759090","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"article-number":"1759090"}}